SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
Cell · 2024-02 · 187 (3) · 596-608.e17
DOI: 10.1016/j.cell.2023.12.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-02. Verfasst von Lu Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, 37073 …. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Institut Pasteur, Lower Saxony State Ministry of Science and Culture.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, 37073 Göttingen, Germany.
- Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany.
- Department of Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany.
- Institute of Virology, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
- Department of Viral Immunology, Helmholtz Zentrum für Infektionsforschung, 38124 Braunschweig, Germany.
- Department of Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany; German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, 30625 Hannover, Germany.
Förderung
- NIAID NIH HHS
- Institut Pasteur
- Lower Saxony State Ministry of Science and Culture
- Horizon Europe
- Bundesministerium für Bildung und Forschung
- Bavarian Research Foundation
- China Scholarship Council
- European Regional Development Fund
Zitieren
APA
Zhang, L., Kempf, A., Nehlmeier, I., Cossmann, A., Richter, A., Bdeir, N., Graichen, L., Moldenhauer, A. S., Dopfer-Jablonka, A., Stankov, M. V., Simon-Loriere, E., Schulz, S. R., Jäck, H. M., Čičin-Šain, L., Behrens, G. M. N., Drosten, C., Hoffmann, M., & Pöhlmann, S. (2024). SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell, 187(3), 596-608.e17. https://doi.org/10.1016/j.cell.2023.12.025
Vancouver
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, et al. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell. 2024;187(3):596-608.e17. doi:10.1016/j.cell.2023.12.025
BibTeX
@article{Zhang2024,
author = {Zhang, Lu and Kempf, Amy and Nehlmeier, Inga and Cossmann, Anne and Richter, Anja and Bdeir, Najat and Graichen, Luise and Moldenhauer, Anna-Sophie and Dopfer-Jablonka, Alexandra and Stankov, Metodi V and Simon-Loriere, Etienne and Schulz, Sebastian R and Jäck, Hans-Martin and Čičin-Šain, Luka and Behrens, Georg M N and Drosten, Christian and Hoffmann, Markus and Pöhlmann, Stefan},
title = {SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency},
journal = {Cell},
year = {2024},
volume = {187},
number = {3},
pages = {596--608.e17},
doi = {10.1016/j.cell.2023.12.025}
}
EUVIMED